Odyssey Thera Announces Collaboration with Mitsubishi Tanabe Pharma Corporation, and Issuance of Core Patent in Japan   ODYSSEY THERA GRANTED U.S. PATENT FOR NOVEL GPCR ASSAY STRATEGY